TipRanks
Laboratorios Farmaceuticos Rovi, SA (DE:41L)
FRANKFURT:41L
Germany Market
41L
Laboratorios Farmaceuticos Rovi
RESEARCH TOOLSreports

Laboratorios Farmaceuticos Rovi (41L) Balance Sheet

4 Followers

Laboratorios Farmaceuticos Rovi Balance Sheet

Laboratorios Farmaceuticos Rovi's total assets for Q2 2026 were €1.13B, an increase of 21.67% from the previous quarter. DE:41L total liabilities were €409.97M for the fiscal quarter, a 71.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
€ 955.69M€ 832.02M€ 799.88M€ 878.70M€ 732.68M
Total Liabilities
€ 276.79M€ 250.48M€ 256.39M€ 357.32M€ 261.70M
Total Equity Gross Minority
€ 675.46M€ 581.54M€ 543.49M€ 521.38M€ 470.98M
Other Metrics
Currency in EUR

Laboratorios Farmaceuticos Rovi Debt to Assets